Legal Representation
Attorney
Tim Burgdorf
USPTO Deadlines
Next Deadline
2014 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250708)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 20, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 20, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 14, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 17, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 17, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 16, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Apr 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 14, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Anti-arthritic compositions and preparations; anti-inflammatories; chemical preparations for pharmaceutical or medical purposes, namely, for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the treatment and prevention of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, namely, rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for auto immune diseases and inflammatory diseases; pharmaceutical preparations for auto immune diseases and inflammatory diseases, namely, arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of joint disease; preparation for the relief of pain
First Use Anywhere:
20160800
First Use in Commerce:
20160800
Additional Information
Design Mark
The mark consists consists of the word "OTREXUP" in Chino Medium font and in the color orange with the letter "O" capitalized. There is a sweeping element in the form of three wave like symbols, the first of which is just above the letter "U" and entirely in the color blue; the second and third wave like symbols begin to the right of the letter "P". The middle wave like symbol is in the color orange except for the top third which is in the color blue and arches over the letter "P". The final wave like symbol is entirely in the color orange and follows the curve of the middle symbol but does not stretch over any of the letters.
Color Claim
The color(s) The color(s) orange and blue is/are claimed as a feature of the mark. is/are claimed as a feature of the mark.
Classification
International Classes
005